Tickner; Derek L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tickner; Derek L..The latest application filed is for "enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-[3-(3-- hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1h-quinolin-2-one and salts thereof, useful in the treatment of cancer".

Company Profile

0.10.13

Tickner; Derek L. - Waterford CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-[3-(3-- hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1H-quinolin-2-one and salts thereof, useful in the treatment of cancer App 20110097315 - Guinn; R. Mark ; et al.	2011-04-28
Substituted quinoline compounds Grant 7,468,378 - Bertinato , et al. December 23, 2	2008-12-23
Triamide-substituted heterobicyclic compounds Grant 7,393,958 - Bertinato , et al. July 1, 2	2008-07-01
Triamide-substituted heterobicyclic compounds Grant 7,368,573 - Bertinato , et al. May 6, 2	2008-05-06
Triamide-substituted heterobicyclic compounds App 20070093525 - Bertinato; Peter ; et al.	2007-04-26
Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-[3-(3-- hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1H-quinolin-2-one and salts thereof, useful in the treatment of cancer Grant 7,176,315 - Guinn , et al. February 13, 2	2007-02-13
Purification process for an azabicyclo[3.1.0]hexane compound Grant 7,153,976 - Tickner , et al. December 26, 2	2006-12-26
Triamide-substituted Heterobicyclic Compounds App 20060223851 - Bertinato; Peter ; et al.	2006-10-05
Substituted quinoline compounds App 20050234099 - Bertinato, Peter ; et al.	2005-10-20
Process for preparing an azabicyclo[3.1.0] hexane compound App 20050075387 - Tickner, Derek L. ; et al.	2005-04-07
Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-- methyl]-4(3-ethynyl-phenyl)-1methyl-1h-quinolin-2-one, 2,3,-dihydroxybutanedioate salts and method of production App 20050020836 - Lyssikatos, Joseph P. ; et al.	2005-01-27
Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-me- thyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1H-quinolin-2-- one and salts thereof, useful in the treatment of cancer App 20040192727 - Guinn, R. Mark ; et al.	2004-09-30
N-(indole-2-carbonyl)-b-alaninamide crystal forms App 20040152758 - Allen, Douglas J. M. ; et al.	2004-08-05
Enantiomers Of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-[3-(3-h Ydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1h-quinolin-2-one And Salts Thereof, Useful In The Treatment Of Cancer Grant 6,740,757 - Guinn , et al. May 25, 2	2004-05-25
Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-(3-ethy nyl-phenyl)-1-methyl-1H-quinolin-2-one, 2,3,- dihydroxybutanedioate salts and method of production Grant 6,734,308 - Lyssikatos , et al. May 11, 2	2004-05-11
Processes and intermediates for preparing glycogen phosphorylase inhibitors Grant 6,696,574 - Barrila , et al. February 24, 2	2004-02-24
N-(indole-2-carbonyl)-b-alaninamide crystal forms Grant 6,683,106 - Allen , et al. January 27, 2	2004-01-27
Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-- methyl]-4-(3-ethynyl-phenyl)-1-methyl-1H-quinolin-2-one, 2,3,- dihydroxybutanedioate salts and method of production App 20030212103 - Lyssikatos, Joseph P. ; et al.	2003-11-13
Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-(3-ethy nyl-phenyl)-1-methyl-1H-quinolin-2-one, 2,3-dihydroxybutanedioate salts and method of production Grant 6,645,982 - Lyssikatos , et al. November 11, 2	2003-11-11
N-(indole-2-carbonyl)-b-alaninamide crystal forms App 20030195243 - Allen, Douglas J. M. ; et al.	2003-10-16
Processes and intermediates for preparing glycogen phosphorylase inhibitors App 20030187051 - Barrila, Mark T. ; et al.	2003-10-02
Enantiomers of 6-[(4-chloro-phenyl)- hydroxy-(3-methyl-3h-imidazol-4-yl)-m- ethyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1- methyl-1h-quinolin-2-one and salts thereof, useful in the treatment of cancer App 20030114487 - Guinn, R. Mark ; et al.	2003-06-19
Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-- methyl]-4-(3-ethynyl-phenyl)-1-methyl-1H-quinolin-2-one, 2,3-dihydroxybutanedioate salts and method of production App 20030032653 - Lyssikatos, Joseph P. ; et al.	2003-02-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.